Evidence map›Paper›PMID 34271420›Full record

ArticleComputational biology and chemistry2021

Efficient machine learning model for predicting drug-target interactions with case study for Covid-19.

Heba El-Behery, Abdel-Fattah Attia, Nawal El-Feshawy, Hanaa Torkey

Open access · greenAbstract read
In one paragraph

Article in Computational biology and chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Staying Ahead of the Game: How SARS-CoV-2 has Accelerated the Application of Machine Learning in Pandemic Management.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2023
    Review
  11. Review
  12. Article
  13. A geometric deep learning model for display and prediction of potential drug-virus interactions against SARS-CoV-2.Chemometrics and intelligent laboratory systems : an international journal sponsored by the Chemometrics Society · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Machine learning prediction of 3CLComputational biology and chemistry · 2022
    Article
  18. Article
  19. Machine Learning in Drug Metabolism Study.Current drug metabolism · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Heba El-BeheryDepartment of Computer Science and Engineering, Faculty of Engineering, Kafrelsheikh University, Kafr_El_Sheikh, Egypt. Electronic address: eng_heba_2010@eng.kfs.edu.eg1.
Abdel-Fattah AttiaDepartment of Computer Science and Engineering, Faculty of Engineering, Kafrelsheikh University, Kafr_El_Sheikh, Egypt. Electronic address: aheliel@eng.kfs.edu.eg2.
Nawal El-FeshawyComputer Science & Engineering Department, Faculty of Electronic Engineering, Menoufia University, Menouf, Egypt. Electronic address: nawal.elfishawy@el-eng.menofia.edu3.
Hanaa TorkeyComputer Science & Engineering Department, Faculty of Electronic Engineering, Menoufia University, Menouf, Egypt. Electronic address: htorkey@el-eng.menofia.edu.eg4.
Kafrelsheikh University · EGMenoufia University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiscover possible Drug Target Interactions (DTIs) is a decisive step in the detection of the effects of drugs as well as drug repositioning. There is a strong incentive to develop effective computational methods that can effectively predict potential DTIs, as traditional DTI laboratory experiments are expensive, time-consuming, and labor-intensive. Some technologies have been developed for this purpose, however large numbers of interactions have not yet been detected, the accuracy of their prediction still low, and protein sequences and structured data are rarely used together in the prediction process.

methodsThis paper presents DTIs prediction model that takes advantage of the special capacity of the structured form of proteins and drugs. Our model obtains features from protein amino-acid sequences using physical and chemical properties, and from drugs smiles (Simplified Molecular Input Line Entry System) strings using encoding techniques. Comparing the proposed model with different existing methods under K-fold cross validation, empirical results show that our model based on ensemble learning algorithms for DTI prediction provide more accurate results from both structures and features data.

resultsThe proposed model is applied on two datasets:Benchmark (feature only) datasets and DrugBank (Structure data) datasets. Experimental results obtained by Light-Boost and ExtraTree using structures and feature data results in 98 % accuracy and 0.97 f-score comparing to 94 % and 0.92 achieved by the existing methods. Moreover, our model can successfully predict more yet undiscovered interactions, and hence can be used as a practical tool to drug repositioning. A case study of applying our prediction model on the proteins that are known to be affected by Corona viruses in order to predict the possible interactions among these proteins and existing drugs is performed. Also, our model is applied on Covid-19 related drugs announced on DrugBank. The results show that some drugs like DB00691 and DB05203 are predicted with 100 % accuracy to interact with ACE2 protein. This protein is a self-membrane protein that enables Covid-19 infection. Hence, our model can be used as an effective tool in drug reposition to predict possible drug treatments for Covid-19.

Indexed as

Drug DevelopmentModels, TheoreticalSARS-CoV-2Amino Acid SequenceAntiviral AgentsCOVID-19COVID-19 Drug TreatmentHumansMachine LearningProteinsAntiviral AgentsProteinsCovid-19Deep-learningDrugsDrug-target interactionsMachine learningPredictionProteins

Identifiers

PMID34271420
PMCPMC8256690
OpenAlexW3177721890

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.